Considering the role of TFEB in modulating AD-related phenotypes, in this study, we investigated the molecular mechanisms by which CC activates TFEB and explored its potential therapeutic role in AD, and found that CC treatment promoted clearance of Aβ plaques and improved cognitive function in the APP/PS1 mouse. The gene discussed is APP; the disease is Alzheimer disease.